Let's Find Opportunities Overseas

Tag: ValueInvesting

Teva Pharmaceuticals stock price on a monitor, with prescription pills and an Israeli flag in the background—symbolizing resurgence and hedge fund interest in TEVA stock.

Teva Pharma: The Funds Believe. Should You?

Hedge fund legend Stanley Druckenmiller just upped his stake in TEVA by 65%—and he’s not alone. With 9 straight quarters of growth, rising biosimilar momentum, and a “Pivot to Growth” strategy in motion, Teva might finally be ready for its rerating. We still like the sandals, but the stock may be worth more than a hike.

Read entire article

Tags: Biosimilars, BiotechStocks, DeepValue, Druckenmiller, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al International Investment Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alInsiders, Funanc1alInsiderSeries, Funanc1alInternational, Funanc1alStocks, GenericDrugs, HedgeFundBuys, InsiderBuying, IsraelStocks, PharmaInvesting, TEVA, ValueInvesting
A cheerful cartoon bull wearing sunglasses, holding a banner with

Coupang (CPNG): Another $37 Million Says... This E-Commerce Giant Isn’t Done Yet

Insiders and hedge funds are piling into Coupang (CPNG)—the Amazon of South Korea—but is it a smart buy or just an expensive gamble? With soaring revenue, strong growth in Eats, Play, and Fintech, and no debt, the company looks solid. But with thin margins, political unrest, and a sky-high P/E of 290, is the stock's future as promising as it seems? 🤔🚀

Read entire article

Tags: BoardBuying, ConvictionTrades, Coupang, CPNG, CPNG Stock, ECommerce, ECommerceAsia, EmergingMarkets, Farfetch, FintechAsia, Funanc1alInternational, Greenoaks, GrowthStocks, HedgeFunds, insider buying, InvestmentIdeas, LuxuryRetailAsia, NeilMehta, SoftBank, SouthKorea, StockMarket, StreamingSouthKorea, ValueInvesting, ValueVsGrowth